Revealing the prognostic and clinicopathological significance of systemic immune-inflammation index in patients with different stage prostate cancer: A systematic review and meta-analysis

BACKGROUND: A novel inflammatory marker called the systemic immune-inflammation index (SII) was applied to predict the prognosis of different cancers. However, the role of SII in prostate cancer (PCa) remains unclear. This systematic review aims to explore the prognostic role of SII in different sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Wenqiang, Zhou, Yongheng, Liu, Zhifeng, Wang, Jian, Lv, Guangda, Zhong, Minglei, Wang, Wenfu, Li, Rongyang, Chen, Shouzhen, Shi, Benkang, Zhu, Yaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659961/
https://www.ncbi.nlm.nih.gov/pubmed/36388917
http://dx.doi.org/10.3389/fmed.2022.1052943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659961/
https://www.ncbi.nlm.nih.gov/pubmed/36388917
http://dx.doi.org/10.3389/fmed.2022.1052943

Ejemplares similares